Table 1: Characteristics of patients with gastrointestinal
mucosal melanomas.
|
Characteristic |
|
Cases (%) |
|
Total |
|
49 |
|
Sex |
Male |
19 (38.8%) |
|
|
Female |
30 (61.2%) |
|
Age (years) |
≤60 |
25 (51.0%) |
|
|
>60 |
24 (49.0%) |
|
Primary or metastatic |
Primary |
43 (87.8%) |
|
|
Metastatic |
6 (12.2%) |
|
Tumor location |
Upper gastrointestinal tract |
8 (16.3%) |
|
|
Lower gastrointestinal tract |
41 (83.7%) |
|
Number of lesions |
Single |
28 (57.1%) |
|
|
Multiple |
7 (14.3%) |
|
|
Unspecified |
14 (28.6%) |
|
Initial symptoms |
Bleeding (haematochezia or haematemesis) |
21 (42.9%) |
|
|
Non-bleeding |
28 (57.1%) |
|
Distant metastasis |
Yes |
16 (32.7%) |
|
|
No |
18 (36.7%) |
|
|
Unspecified |
15 (30.6%) |
|
Lymph node metastasis |
Yes |
27 (55.1%) |
|
|
No |
8 (16.3%) |
|
|
Unspecified |
14 (28.6%) |
|
Melan A (immunohistochemical analysis) |
(+) |
33 (67.3%) |
|
|
(-) |
13 (26.5%) |
|
|
Unspecified |
3 (6.1%) |
|
Treatments |
No (had not received any treatment or had received only
palliative care) |
12 (24.5%) |
|
|
Only surgery |
19 (38.8%) |
|
|
Only chemotherapy |
1 (2.0%) |
|
|
Both surgery and chemotherapy |
17 (34.7%) |